PW Medtech Group (1358.HK) Stock Price

PW Medtech Group Price

HKEX·CLOSED
0.80CNY+0.00 (+0.00 %)
Market closed

Revenue has compounded at 19.0% per year over the past 15 years to 957.28 M CNY. Earnings per share have grown at 4.4% per year over the last 13 years. PW Medtech Group's net margin stands at 11.5%, down from 272.3% several years earlier. PW Medtech Group currently offers a dividend yield of about 12.12%. The payout ratio is around 117% of earnings.

PW Medtech Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of PW Medtech Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how PW Medtech Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing PW Medtech Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

PW Medtech Group Stock Price History
DatePW Medtech Group Price
8/12/20260.80 CNY
8/11/20260.80 CNY
8/10/20260.87 CNY
8/7/20260.87 CNY
8/6/20260.87 CNY
8/5/20260.88 CNY
8/4/20260.88 CNY
8/3/20260.88 CNY
7/31/20260.87 CNY
7/30/20260.89 CNY
7/29/20260.90 CNY
7/28/20260.92 CNY
7/27/20260.90 CNY
7/24/20260.92 CNY
7/23/20260.91 CNY
7/22/20260.92 CNY
7/21/20260.91 CNY
7/20/20260.91 CNY
7/17/20260.92 CNY
7/16/20260.93 CNY
7/15/20260.93 CNY
7/14/20260.92 CNY
7/13/20260.89 CNY
7/10/20260.94 CNY
7/9/20260.94 CNY
7/8/20260.94 CNY
7/7/20260.95 CNY
7/6/20260.94 CNY
7/3/20260.95 CNY
7/2/20260.94 CNY
6/30/20260.95 CNY
6/29/20260.96 CNY
6/26/20260.98 CNY
6/25/20260.96 CNY
6/24/20260.98 CNY
6/23/20260.99 CNY
6/22/20260.99 CNY
6/18/20260.99 CNY
6/17/20260.99 CNY
6/16/20260.99 CNY
6/15/20261.00 CNY
6/12/20260.99 CNY
6/11/20260.99 CNY
6/10/20261.00 CNY
6/9/20261.00 CNY
6/8/20261.00 CNY
6/5/20261.01 CNY
6/4/20261.01 CNY
6/3/20261.02 CNY
6/2/20261.02 CNY
6/1/20261.01 CNY
5/29/20261.00 CNY
5/28/20261.02 CNY
5/27/20261.00 CNY
5/26/20261.02 CNY
5/22/20261.02 CNY
5/21/20261.02 CNY
5/20/20261.02 CNY
5/19/20261.01 CNY
5/18/20261.01 CNY
5/15/20261.01 CNY
5/14/20261.02 CNY
5/13/20261.03 CNY
5/12/20261.03 CNY
5/11/20261.02 CNY
5/8/20261.03 CNY
5/7/20261.02 CNY
5/6/20261.01 CNY
5/5/20261.02 CNY
5/4/20261.00 CNY
4/30/20260.98 CNY
4/29/20260.97 CNY
4/28/20261.00 CNY
4/27/20261.04 CNY
4/24/20261.03 CNY
4/23/20261.02 CNY
4/22/20261.02 CNY
4/21/20261.02 CNY
4/20/20261.02 CNY
4/17/20261.02 CNY
4/16/20261.00 CNY
4/15/20261.00 CNY
4/14/20260.98 CNY
4/13/20260.98 CNY
4/10/20260.98 CNY
4/9/20260.95 CNY
4/8/20260.99 CNY
4/2/20260.94 CNY
4/1/20260.93 CNY
3/31/20260.91 CNY
3/30/20260.91 CNY
3/27/20260.90 CNY
3/26/20260.89 CNY
3/25/20260.91 CNY
3/24/20260.91 CNY
3/23/20260.89 CNY
3/20/20260.91 CNY
3/19/20260.90 CNY
3/18/20260.92 CNY
3/17/20260.95 CNY
3/16/20260.96 CNY
3/13/20260.96 CNY
3/12/20260.97 CNY
3/11/20260.94 CNY
3/10/20260.94 CNY
3/9/20261.12 CNY
3/6/20261.14 CNY
3/5/20261.13 CNY
3/4/20261.13 CNY
3/3/20261.13 CNY
3/2/20261.13 CNY
2/27/20261.18 CNY
2/26/20261.21 CNY
2/25/20261.21 CNY
2/24/20261.21 CNY
2/23/20261.20 CNY
2/20/20261.18 CNY
2/16/20261.18 CNY
2/13/20261.18 CNY
2/12/20261.16 CNY
2/11/20261.18 CNY
2/10/20261.17 CNY
2/9/20261.17 CNY
2/6/20261.17 CNY
2/5/20261.13 CNY
2/4/20261.13 CNY
2/3/20261.13 CNY
2/2/20261.13 CNY
1/30/20261.13 CNY
1/29/20261.13 CNY
1/28/20261.14 CNY
1/27/20261.13 CNY
1/26/20261.12 CNY
1/23/20261.11 CNY
1/22/20261.11 CNY
1/21/20261.08 CNY
1/20/20261.11 CNY
1/19/20261.13 CNY
1/16/20261.14 CNY
1/15/20261.13 CNY
1/14/20261.15 CNY
1/13/20261.14 CNY
1/12/20261.13 CNY
1/9/20261.13 CNY
1/8/20261.11 CNY
1/7/20261.14 CNY
1/6/20261.13 CNY
1/5/20261.14 CNY
1/2/20261.14 CNY
12/31/20251.13 CNY
12/30/20251.13 CNY
12/29/20251.13 CNY
12/24/20251.14 CNY
12/23/20251.14 CNY
12/22/20251.16 CNY
12/19/20251.17 CNY
12/18/20251.11 CNY
12/17/20251.10 CNY
12/16/20251.13 CNY
12/15/20251.16 CNY
12/12/20251.17 CNY
12/11/20251.17 CNY
12/10/20251.19 CNY
12/9/20251.18 CNY
12/8/20251.17 CNY
12/5/20251.17 CNY
12/4/20251.18 CNY
12/3/20251.19 CNY
12/2/20251.20 CNY
12/1/20251.21 CNY
11/28/20251.18 CNY
11/27/20251.18 CNY
11/26/20251.20 CNY
11/25/20251.18 CNY
11/24/20251.18 CNY
11/21/20251.17 CNY
11/20/20251.19 CNY
11/19/20251.20 CNY
11/18/20251.20 CNY
11/17/20251.21 CNY
11/14/20251.23 CNY
11/13/20251.23 CNY
11/12/20251.25 CNY
11/11/20251.23 CNY
11/10/20251.22 CNY
11/7/20251.22 CNY
11/6/20251.21 CNY
11/5/20251.23 CNY
11/4/20251.27 CNY
11/3/20251.30 CNY
10/31/20251.33 CNY
10/30/20251.33 CNY
10/28/20251.29 CNY
10/27/20251.29 CNY
10/24/20251.29 CNY
10/23/20251.29 CNY
10/22/20251.30 CNY
10/21/20251.32 CNY
10/20/20251.31 CNY
10/17/20251.28 CNY
10/16/20251.28 CNY
10/15/20251.31 CNY
10/14/20251.28 CNY
10/13/20251.30 CNY
10/10/20251.29 CNY
10/9/20251.34 CNY
10/8/20251.33 CNY
10/6/20251.33 CNY
10/3/20251.34 CNY
10/2/20251.33 CNY
9/30/20251.35 CNY
9/29/20251.39 CNY
9/26/20251.38 CNY
9/25/20251.38 CNY
9/24/20251.39 CNY
9/23/20251.41 CNY
9/22/20251.39 CNY
9/19/20251.42 CNY
9/18/20251.37 CNY
9/17/20251.35 CNY
9/16/20251.35 CNY
9/15/20251.35 CNY
9/12/20251.35 CNY
9/11/20251.33 CNY
9/10/20251.34 CNY
9/9/20251.32 CNY
9/8/20251.30 CNY
9/5/20251.25 CNY
9/4/20251.23 CNY
9/3/20251.23 CNY
9/2/20251.23 CNY
9/1/20251.23 CNY
8/29/20251.27 CNY
8/28/20251.23 CNY
8/27/20251.25 CNY
8/26/20251.28 CNY
8/25/20251.27 CNY
8/22/20251.26 CNY
8/21/20251.28 CNY
8/20/20251.26 CNY
8/19/20251.23 CNY
8/18/20251.22 CNY
8/15/20251.23 CNY
Access this data via the Eulerpool API
Get Free API Key

PW Medtech Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
361.30 M CNY
71.85 M CNY
133.46 M CNY
Jan 1, 2019
421.02 M CNY
47.50 M CNY
95.30 M CNY
Jan 1, 2020
287.53 M CNY
-28.70 M CNY
734.45 M CNY
Jan 1, 2021
315.49 M CNY
791.32 M CNY
859.19 M CNY
Jan 1, 2022
624.03 M CNY
142.80 M CNY
123.27 M CNY
Jan 1, 2023
675.08 M CNY
187.40 M CNY
153.18 M CNY
Jan 1, 2024
768.90 M CNY
179.48 M CNY
150.78 M CNY
Jan 1, 2025
957.28 M CNY
142.17 M CNY
109.71 M CNY

PW Medtech Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 7:24 AM
 
REVENUEM CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESB
2010201120122013201420152016201720182019202020212022202320242025
70.00203.00385.00531.00706.00599.00371.00333.00361.00421.00287.00315.00624.00675.00768.00957.00
–190.0089.6637.9232.96-15.16-38.06-10.248.4116.62-31.839.7698.108.1713.7824.61
675.71233.0065.9767.8072.8074.9665.7760.6662.6061.2859.9361.2755.6156.3054.5649.43
473.00473.00254.00360.00514.00449.00244.00202.00226.00258.00172.00193.00347.00380.00419.00473.00
22.0071.00149.00200.00278.00278.00136.0051.0071.0047.00-28.00791.00142.00187.00179.00142.00
31.4334.9838.7037.6639.3846.4136.6615.3219.6711.16-9.76251.1122.7627.7023.3114.84
––51.0090.00205.00242.00126.005.00133.0095.00734.00859.00123.00153.00150.00109.00
–––76.47127.7818.05-47.93-96.032,560.00-28.57672.6317.03-85.6824.39-1.96-27.33
–––––––––––1.58–0.100.090.10
––––––––––––––-10.0011.11
1.541.661.281.391.721.691.611.581.571.571.571.571.571.571.521.54
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales PW Medtech Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue PW Medtech Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare PW Medtech Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares PW Medtech Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against PW Medtech Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

PW Medtech Group stock margins

The PW Medtech Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of PW Medtech Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for PW Medtech Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
62.82 %
19.89 %
36.94 %
Jan 1, 2019
61.33 %
11.28 %
22.64 %
Jan 1, 2020
60.08 %
-9.98 %
255.43 %
Jan 1, 2021
61.19 %
250.82 %
272.34 %
Jan 1, 2022
55.67 %
22.88 %
19.75 %
Jan 1, 2023
56.42 %
27.76 %
22.69 %
Jan 1, 2024
54.55 %
23.34 %
19.61 %
Jan 1, 2025
49.48 %
14.85 %
11.46 %

PW Medtech Group Stock Revenue, EBIT, Earnings per Share

The PW Medtech Group earnings per share therefore indicates how much revenue PW Medtech Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.23 CNY
0.05 CNY
0.09 CNY
Jan 1, 2019
0.27 CNY
0.03 CNY
0.06 CNY
Jan 1, 2020
0.18 CNY
-0.02 CNY
0.47 CNY
Jan 1, 2021
0.20 CNY
0.50 CNY
0.55 CNY
Jan 1, 2022
0.40 CNY
0.09 CNY
0.08 CNY
Jan 1, 2023
0.43 CNY
0.12 CNY
0.10 CNY
Jan 1, 2024
0.51 CNY
0.12 CNY
0.10 CNY
Jan 1, 2025
0.62 CNY
0.09 CNY
0.07 CNY

PW Medtech Group business model & stock analysis

The PW Medtech Group Ltd is a leading global company for the manufacturing of medical implants and instruments for orthopedic surgery. The company is headquartered in Hong Kong and has distribution and manufacturing facilities worldwide.

PW Medtech Group SWOT Analysis

Strengths

1. Strong product portfolio: PW Medtech Group Ltd offers a wide range of innovative medical technology products.

2. Established brand reputation: The company is well-known for its reliable and high-quality medical devices.

3. Extensive distribution network: PW Medtech Group Ltd has a strong presence in various markets around the world.

Weaknesses

1. Dependence on key suppliers: The company relies heavily on certain suppliers for its components and raw materials.

2. Limited market diversification: PW Medtech Group Ltd is primarily focused on specific segments of the medical technology industry, which may expose it to market fluctuations.

3. Regulatory challenges: Compliance with stringent regulations in different regions can pose challenges for the company.

Opportunities

1. Growing demand for medical technology: The increasing global healthcare expenditure and aging population provide a significant opportunity for the company to expand its market share.

2. Expansion into emerging markets: PW Medtech Group Ltd can leverage its strong distribution network to enter new and emerging markets, tapping into the unmet needs of these regions.

3. Technological advancements: The rapid development of new technologies in the medical field opens doors for PW Medtech Group Ltd to introduce innovative solutions and stay ahead of its competitors.

Threats

1. Intense competition: The medical technology industry is highly competitive, with numerous players vying for market share.

2. Economic uncertainties: Economic downturns and financial instability in different regions can impact the demand for medical devices and the company's profitability.

3. Intellectual property infringement: There is a risk of unauthorized use, reproduction, or counterfeiting of the company's intellectual property, which could affect its market position and revenue.

PW Medtech Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

PW Medtech Group historical P/E ratio, EBIT multiple, and P/S ratio

PW Medtech Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

PW Medtech Group shares outstanding

The number of shares of PW Medtech Group was 1.54 B in 2025. This indicates how many shares PW Medtech Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
1.57 B Stocks
Jan 1, 2019
1.57 B Stocks
Jan 1, 2020
1.57 B Stocks
Jan 1, 2021
1.57 B Stocks
Jan 1, 2022
1.57 B Stocks
Jan 1, 2023
1.57 B Stocks
Jan 1, 2024
1.52 B Stocks
Jan 1, 2025
1.54 B Stocks

PW Medtech Group Dividend History

5 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20250.10CNY↑ 2.6%2×
Jul 3, 20250.05CNY↑ 17.8%1/2
Nov 3, 20250.04CNY↓ 17.0%2/2
20240.09CNY↑ 92.9%2×
20230.05CNY↓ 96.9%1×
20211.58CNY 0.0%1×
20201.58CNY——

PW Medtech Group dividend history and estimates

In 2025, PW Medtech Group paid a dividend amounting to 0.10 CNY. Dividend means that PW Medtech Group distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Special dividend
Details
Date
Dividend
Dividend (Estimate)
Special dividend
Jan 1, 2020 (e)
1.58 CNY
0.00 CNY
0.00 CNY
Jan 1, 2021 (e)
0.00 CNY
1.58 CNY
0.00 CNY
Jan 1, 2023 (e)
0.05 CNY
0.05 CNY
0.00 CNY
Jan 1, 2024
0.09 CNY
0.00 CNY
0.00 CNY
Jan 1, 2025
0.10 CNY
0.00 CNY
0.00 CNY

PW Medtech Group dividend payout ratio

In 2025, PW Medtech Group had a payout ratio of 116.81%. The payout ratio indicates the percentage of the company's profits that PW Medtech Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
80.66 %
Jan 1, 2019
80.66 %
Jan 1, 2020
80.66 %
Jan 1, 2021
247.83 %
Jan 1, 2022
80.66 %
Jan 1, 2023
43.10 %
Jan 1, 2024
82.07 %
Jan 1, 2025
116.81 %
Price targets and forecasts for PW Medtech Group are not yet available.

PW Medtech Group shareholder structure

% Name
0.49448%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.06058%
AXA Investment Managers UK Ltd.
AXA Investment Managers UK Ltd.
0.03803%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.00045%
American Century Investment Management, Inc.
American Century Investment Management, Inc.

PW Medtech Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
31.8%
Float Shares
-
Shares Outstanding
-

PW Medtech Group Executives and Management Board

10 members · avg. age 52 · 40 % women

YZ

Ms. Yue'e Zhang (58)

Chief Executive Officer, Executive Chairman of the Board · since 2013

1.26 M CNY

Management

YC

Mr. Yikun Chen (45)

Vice President

–
WH

Mr. Wei Hua (51)

Vice President · since 2011

–
KS

Ms. Ka Man So

Company Secretary

–

Board of Directors

LJ

Mr. Liwei Jiang (54)

Non-Executive Director · since 2013

600,000.00 CNY
JL

Mr. Junshan Lin (59)

Non-Executive Director

600,000.00 CNY
GC

Mr. Geng Chen (51)

Independent Non-Executive Director

466,000.00 CNY
XW

Mr. Xiaogang Wang (48)

Independent Non-Executive Director

466,000.00 CNY
FW

Ms. Fengli Wang (59)

Independent Non-Executive Director

69,000.00 CNY
TT

Ms. Tian Tian (39)

Financial Director

–

PW Medtech Group Supply Chain

PW Medtech Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#NameTrend
1
China Biologic Products Holdings, Inc.
Supplier·Customer·CN
-0.77
-0.39
0.17
-0.29
—
—
2
Essentra
Supplier·Customer·Chemicals·GB
-0.35
0.13
-0.36
0.25
-0.56
0.02

Frequently asked questions about PW Medtech Group

The business model of PW Medtech Group Ltd is focused on the development, manufacturing, and distribution of medical devices. As a leading healthcare company, PW Medtech Group Ltd works towards enhancing patient care by providing innovative and high-quality products. With a diverse portfolio, they cater to various medical fields including orthopedics, cardiovascular, and neurosurgery. Through strategic partnerships and acquisitions, PW Medtech Group Ltd aims to expand its market presence globally and strengthen its position as a trusted provider of medical solutions.

PW Medtech Group Ltd is primarily active in the medical technology industry.

The main competitors of PW Medtech Group Ltd in the market are [competitor1], [competitor2], and [competitor3]. These companies compete with PW Medtech Group Ltd in the [specific industry/sector]. While PW Medtech Group Ltd offers [specific products/services], its competitors also provide similar offerings to the market. This fierce competition drives innovation and pushes PW Medtech Group Ltd to constantly enhance its products and services to stay ahead in the market.

PW Medtech Group Ltd is a leading medical device company with a rich history and background. Established in [year], PW Medtech Group Ltd has become a trusted name in the industry, specializing in [specific medical devices or areas of expertise]. With a strong focus on innovation, quality, and customer satisfaction, the company has continually evolved and expanded its product portfolio. Renowned for its cutting-edge technology and commitment to improving patient outcomes, PW Medtech Group Ltd has earned a remarkable reputation worldwide. Leveraging its extensive experience and strategic partnerships, the company remains dedicated to driving advancements in the field of medical technology, making a positive impact on global healthcare.

PW Medtech Group Ltd has achieved several significant milestones throughout its history. As a leading medical device company, PW Medtech has constantly strived to innovate in the healthcare industry. Some notable accomplishments include successful product launches, expansion into new markets, and strategic collaborations with renowned institutions. The company has also received numerous awards and recognition for its contributions to the medical field. These achievements are a testament to PW Medtech's commitment to delivering high-quality medical solutions and improving patient care.

PW Medtech Group Ltd is primarily present in China and the Asia-Pacific region. With its headquarters located in China, PW Medtech Group Ltd focuses on the development and manufacturing of medical devices and equipment. It has a strong presence in major cities and provinces across China, where it serves a significant market share. Additionally, PW Medtech Group Ltd has expanded its operations in the Asia-Pacific region, including countries such as Japan, South Korea, Singapore, and Australia. By strategically targeting these regions, PW Medtech Group Ltd aims to capitalize on the growing demand for advanced medical technology and enhance its global footprint.

PW Medtech Group Ltd represents values of innovation, excellence, and integrity. As a medical technology company, they prioritize delivering advanced and reliable solutions to improve patients' lives. Their corporate philosophy revolves around continuous research and development, ensuring high product quality and safety standards. PW Medtech Group Ltd is committed to collaborative partnerships with healthcare professionals, fostering trust and providing tailored solutions to meet evolving medical needs. With a customer-centric approach, they aim to enhance the overall healthcare experience and contribute to the sustainable development of the industry.

9 analysts currently rate the PW Medtech Group stock: 0 recommend buying, 3 holding and 6 selling.

PW Medtech Group Analyst Price Targets 2026

Converted at the current exchange rate, the PW Medtech Group share trades at 0.10 EUR (0.80 CNY).

The PW Medtech Group share (1358.HK) is listed on 2 stock exchanges, including: Frankfurt (PWE.F).

The PW Medtech Group Ltd is a leading company in the field of medical technology, specializing in the manufacturing and sale of products and services related to medical devices. The company is headquartered in Hong Kong and has branches in China, Hong Kong, and Singapore. The business model of the PW Medtech Group Ltd includes several divisions, including the manufacturing of medical devices, the development and marketing of medications, and the provision of medical services. The different divisions complement each other and allow the company to offer a comprehensive range of products and services tailored to the needs of customers. The manufacturing of medical devices is one of the main divisions of the PW Medtech Group Ltd. The company produces a variety of devices, including surgical instruments, implants, artificial joints, and other medical devices. PW Medtech Group's products are known for their high quality, reliability, and innovative features that meet the needs of doctors and patients. Another important division of the company is the development and marketing of medications. In recent years, PW Medtech Group has developed and brought to market a wide range of medications, including drugs for the treatment of cancer, diabetes, and other chronic diseases. By developing and marketing medications, the company makes a significant contribution to improving healthcare. In addition to manufacturing medical devices and developing medications, PW Medtech Group Ltd also offers a range of medical services. These include providing consulting services to doctors and hospitals, training for medical personnel, and diagnostic and treatment services for patients. These services are of great value to customers and contribute to making PW Medtech Group Ltd a comprehensive provider of medical technology. The products offered by PW Medtech Group Ltd include a wide range of medical devices and consumables. These include surgical instruments, implants, artificial joints, wound dressings, bandages, gloves, and masks. All products have been carefully designed and tested to ensure the highest standards of quality and safety. In summary, the business model of the PW Medtech Group Ltd is based on a wide range of products and services in the field of medical technology. The different divisions complement each other and allow the company to provide a comprehensive range of products and services that meet the needs of customers. By providing high-quality medical technology and medications, as well as top-notch medical services, PW Medtech Group Ltd makes a significant contribution to improving healthcare and enhancing the quality of life for patients.

The revenue cannot currently be calculated for PW Medtech Group.

The profit cannot currently be calculated for PW Medtech Group.

The P/E ratio cannot be calculated for PW Medtech Group at the moment.

The P/S cannot be calculated for PW Medtech Group currently.

The Eulerpool Quality Score for PW Medtech Group is 3/10.

The ISIN of PW Medtech Group is KYG7306W1087. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of PW Medtech Group is A1W74W. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of PW Medtech Group is 1358.HK. The ticker symbol is used to trade PW Medtech Group shares on the stock exchange.

Over the past 12 months, PW Medtech Group paid a dividend of 0.10 CNY . This corresponds to a dividend yield of about 12.12 %. For the coming 12 months, PW Medtech Group is expected to pay a dividend of 0.10 CNY.

The current dividend yield of PW Medtech Group is 12.12 %.

PW Medtech Group pays a dividend, distributed in the months of , , , .

PW Medtech Group paid dividends every year for the past 3 years.

For the upcoming 12 months, dividends amounting to 0.10 CNY are expected. This corresponds to a dividend yield of 12.12 %.

PW Medtech Group is assigned to the 'Health' sector.

To receive the latest dividend of PW Medtech Group from amounting to 0.04 CNY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, PW Medtech Group distributed 0.09 CNY as dividends.

The dividends of PW Medtech Group are distributed in CNY.

All fundamentals and in-depth analysis of PW Medtech Group

Our stock analysis for PW Medtech Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PW Medtech Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

PW Medtech Group Stock
PW Medtech Group Revenue→
PW Medtech Group Stock
PW Medtech Group Net Income→
PW Medtech Group Stock
PW Medtech Group P/E→
PW Medtech Group Stock
PW Medtech Group P/S→
PW Medtech Group Stock
PW Medtech Group EBIT→
PW Medtech Group Stock
PW Medtech Group Dividend→
PW Medtech Group Stock
PW Medtech Group Directors Dealings→
PW Medtech Group Stock
PW Medtech Group Stocks→
PW Medtech Group Stock
PW Medtech Group Market capitalization→
PW Medtech Group Stock
PW Medtech Group Debt→
PW Medtech Group Stock
PW Medtech Group Liabilities→
PW Medtech Group Stock
PW Medtech Group Equity→
PW Medtech Group Stock
PW Medtech Group AAQS→
PW Medtech Group Stock
PW Medtech Group Employees→
PW Medtech Group Stock
PW Medtech Group ROE→
PW Medtech Group Stock
PW Medtech Group ROA→
PW Medtech Group Stock
PW Medtech Group ROCE→
PW Medtech Group Stock
PW Medtech Group News→
PW Medtech Group Stock
PW Medtech Group Analyst Price Targets→

Health Stocks

PYC TherapeuticsPuriblood Medical CoPyridam Farma Tbk PTPure BiologicsPyxis OncologyPuraPharm CorpPZ CormayPuma BiotechnologyPZ Wind DownPulsenmoreQ & M Dental Group (Singapore)Pulse BiosciencesAll Stocks A–Z →